# Veraxa Biotech AG (VRXA)

Source: https://www.quantisnow.com/company/VRXA
Generated: 2026-11-12T02:16:41.518Z

- Ticker: VRXA
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- SEC CIK: 0002079109
- Website: https://www.veraxa.com

## About

At VERAXA, we are building a premier engine for the discovery and development of next-generation antibody-based therapeutics, including bispecific T cell engagers, bispecific ADCs and other innovative formats. Powered by a suite of transformative technologies and guided by rigorous quality-by-design principles, we are rapidly advancing our pipeline of ADCs and proprietary BiTAC formats into clinical development and beyond. VERAXA was founded on scientific breakthroughs made at the European Molecular Biology Laboratory (EMBL), a world-renowned institution known for pioneering life science research and cutting-edge technology.

## Latest VRXA news and filings

No events on the wire yet.

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/VRXA
- Earnings history: https://www.quantisnow.com/earnings/VRXA
- Dividend history: https://www.quantisnow.com/dividends/VRXA
- Insider transactions: https://www.quantisnow.com/insiders/VRXA
- Options chain: https://www.quantisnow.com/options/VRXA
- SEC 8-K filings only: https://www.quantisnow.com/company/VRXA/8-k
- RSS and alerts for VRXA: https://www.quantisnow.com/docs/rss-feeds.md